Sub-millimetric, patient-specific brain targeting for functional neurosurgery and real-world outcomes in Parkinson’s Disease and Essential Tremor.

ActuIA Features RebrAIn’s Innovations in Supervised AI-Driven Deep Brain Stimulation

We are excited to share that RebrAIn has been featured by ActuIA for our innovative work in neurosurgical targeting for Deep Brain Stimulation (DBS).

The article highlights our supervised AI-driven solutions that significantly improve patient outcomes for those with Parkinson’s Disease and Essential Tremor. Founded by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, RebrAIn is transforming the landscape of neurosurgery with our precise and effective treatments.

Read the full article, “Focus on RebrAIn, the start-up that aims to revolutionize the surgical targeting of Deep Brain Stimulation”, in French on actuia.com here.

An English translation by Google is available here.

Our latest public updates

Rebrain at WSSFN 2026

Rebrain at WSSFN 2026

Sep 17, 2026

Rebrain will take part in the 2026 World Society for Stereotactic and Functional Neurosurgery Congress (WSSFN), held at the Palais du Pharo in Marseille from September 30 to October 3. You will find the team, in the exhibition foyer next to the main entrance. Born...

Rebrain x Worldwide Dystonia Research Center

Rebrain x Worldwide Dystonia Research Center

May 28, 2026

Partnership aims to develop next-generation data-driven models for personalized deep brain stimulation (DBS) targeting, expanding clinical applications from Parkinson’s disease and essential tremor to dystonia and severe pediatric dystonia with global scalability...